Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions
Cancers · 15.08.2025 · 17 (16) · 2667
DOI: 10.3390/cancers17162667 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 15.08.2025. Verfasst von Saad Ahmad und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The oral microbiome has been implicated in the pathogenesis of head and neck squamous cell carcinoma (HNSCC). This review examines the association between specific oral bacterial taxa and HNSCC.
Methods
A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to examine the relationship between the oral microbiome and HNSCC. A comprehensive literature search was conducted in databases including EMBASE, Cochrane Library, Web of Science, Medline, and PubMed.
Results
Following the screening of 284 articles, 21 studies met the inclusion criteria, comprising 1023 HNSCC patients (male: n = 806, 79%; female: n = 217, 21%) and 837 healthy controls (male: n = 622, 74%; female: n = 215, 25.7%). Although findings on alpha diversity were inconsistent, a significant difference in beta diversity was consistently reported between HNSCC patients and healthy controls. HNSCC patients exhibited higher relative abundances of Firmicutes and Synergistetes at the phylum level; Fusobacterium, Prevotella, Porphyromonas, Parvimonas, and Peptostreptococcus at the genus level; and Fusobacterium nucleatum, Prevotella intermedia, Lactobacillus spp., and Porphyromonas gingivalis at the species level. In contrast, healthy controls showed higher abundances of Proteobacteria and Actinobacteria at the phylum level; Streptococcus, Actinomyces, Corynebacterium, Rothia, and Veillonella at the genus level; and Haemophilus influenzae, Rothia mucilaginosa, and Streptococcus mitis at the species level in most studies.
Conclusions
The findings indicate distinct alterations in oral microbiome diversity and composition among HNSCC patients, highlighting the role of microbial dysbiosis in cancer progression. Standardized protocols for oral sample collection and microbiota analysis are essential to facilitate more robust, comparable, and clinically meaningful research outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.
- Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
- Bowel Cancer and Biomarker Laboratory, Kolling Institute, St Leonards, NSW 2065, Australia.
- Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, St Leonards, NSW 2065, Australia.
ORCID-Profile: Anna Lawless, Alexander Guminski, Alexander Yuile, Mark Molloy, Byeongsang Oh
Zitieren
APA
Ahmad, S., Jayamanne, D., Bergamin, S., Lawless, A., Guminski, A., Lee, A., Yuile, A., Wheeler, H., Eade, T., Back, M., Molloy, M., & Oh, B. (2025). Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions. Cancers, 17(16), 2667. https://doi.org/10.3390/cancers17162667
Vancouver
Ahmad S, Jayamanne D, Bergamin S, Lawless A, Guminski A, Lee A, et al. Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions. Cancers. 2025;17(16):2667. doi:10.3390/cancers17162667
BibTeX
@article{Ahmad2025,
author = {Ahmad, Saad and Jayamanne, Dasantha and Bergamin, Sarah and Lawless, Anna and Guminski, Alexander and Lee, Adrian and Yuile, Alexander and Wheeler, Helen and Eade, Thomas and Back, Michael and Molloy, Mark and Oh, Byeongsang},
title = {Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions},
journal = {Cancers},
year = {2025},
volume = {17},
number = {16},
pages = {2667},
doi = {10.3390/cancers17162667}
}
EUVIMED